Hudson Bay Capital Management LP Regenxbio Inc. Transaction History
Hudson Bay Capital Management LP
- $21.9 Billion
- Q3 2024
A detailed history of Hudson Bay Capital Management LP transactions in Regenxbio Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 215,000 shares of RGNX stock, worth $1.64 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
215,000
Previous 165,000
30.3%
Holding current value
$1.64 Million
Previous $1.93 Million
16.84%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding RGNX
# of Institutions
196Shares Held
43MCall Options Held
104KPut Options Held
478K-
Black Rock Inc. New York, NY8.61MShares$65.6 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.89MShares$37.3 Million3.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.37MShares$33.3 Million0.0% of portfolio
-
State Street Corp Boston, MA2.78MShares$21.2 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.48MShares$18.9 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $329M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...